Severe Community-acquired Pneumonia Due to Legionella pneumophila Serogroup 6  by Chen, Chung-Yu et al.
256 J Formos Med Assoc | 2006 • Vol 105 • No 3
C.Y. Chen, et al
Legionella pneumophila is a common cause of sporadic community-acquired pneumonia, but culture-proven
legionellosis is rarely diagnosed. There is no laboratory test for Legionnaires’ disease that can detect all patients
with the disease. Culture is the standard diagnostic method and should be initiated as soon as possible in
suspected cases. We describe a rare case of community-acquired pneumonia caused by L. pneumophila sero-
group 6. A 77-year-old man was admitted to a tertiary care hospital because of high fever, productive cough,
and progressive dyspnea. Chest radiography showed bilateral pneumonia, which led to respiratory failure
necessitating mechanical ventilatory support. Despite antibiotic therapy, his condition continued to deteriorate
and acute renal failure also developed. Urine was negative for L. pneumophila. Culture of the sputum yielded
L. pneumophila serogroup 6, although there was no elevation of the serum antibody titer. Pneumonia resolved
gradually and he was extubated after treatment with levofloxacin followed by erythromycin. L. pneumophila
other than serogroup 1 should be included in the differential diagnosis of patients with suspected atypical
community-acquired pneumonia. [J Formos Med Assoc 2006;105(3):256–262]
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Legionella pneumophila is a common bacterial path-
ogen of severe community-acquired or nosocomi-
al pneumonia, most frequently found in immuno-
logically deficient subjects or in the elderly.1 Since
Legionnaires’ disease is not readily recognizable
by clinical manifestations, specialized laboratory
tests are essential for diagnosis. Among these, cul-
ture is the most specific and widely accepted as
the gold standard. In routine laboratory work-up,
however, culture-proven legionellosis is rarely
diagnosed.
Forty-two Legionella species with 64 serogroups
have been classified to date, and L. pneumophila
is classified serologically into 15 serogroups.2 L.
pneumophila serogroup 6 is the second most
common serogroup according to the frequency
of isolation from clinical samples.3,4 Moreover, L.
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pneumophila serogroup 6 remains an important
etiology of nosocomial Legionnaires’ disease and
may infect through contaminated water supply
systems or medical instruments.5–8
Here, we report a case of community-acquired
pneumonia due to L. pneumophila serogroup 6.
The previous related medical literature is also re-
viewed.
Case Report
A 77-year-old man had chronic productive cough
for several years. He had smoked one pack of
cigarettes per day for 50 years. During the pre-
vious 6 months, he experienced progressive
dyspnea on exertion. He visited a local hospital 3
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breaths per minute, and blood pressure was 152/
76 mmHg. On physical examination, the patient
was conscious and coherent. There were no remark-
able head and neck findings and no lymphaden-
opathies were palpable. Diffuse crackles were
heard on both lung fields. Heart rhythm was re-
gular without audible murmur. There were also
no significant thoracic or abdominal findings.
There was no peripheral edema, clubbed digits,
or cyanosis. Results of the neurologic examination
were, likewise, unremarkable. The hemogram and
results of blood chemistry study are shown in the
Table.
Levofloxacin (500 mg/day) was administered
intravenously under the impression of severe com-
munity-acquired pneumonia after admission.
Urine pneumococcal antigen, Legionella antigen
test, and serology of Mycoplasma and Chlamydia
were all negative. However, chest radiography re-
vealed rapid progression of pneumonic patches
with bilateral lung involvement (Figure 1C).
Arterial blood gas showed that partial pressure
of oxygen (PaO2) was 56 mmHg, partial pressure
of carbon dioxide (PaCO2) was 24 mmHg, and
pH was 7.42 under oxygen support by a non-
rebreathing mask. He was intubated due to hy-
poxic respiratory failure 2 days after admission.
High-resolution computed tomography revealed
bilateral diffuse reticulation and ground glass
opacity (Figure 2). Minimal right pleural effusion
and patchy consolidation of both lower lobes with
months before admission, when abnormal renal
and heart functions were noted. However, there
was no orthopnea or bipedal edema. Moreover,
frequent gouty arthritic attacks and aggravated
productive cough occurred in the 2 weeks before
admission. The patient self-medicated with some
analgesics and prednisolone for symptom relief.
Fever, chills and dyspnea developed 1 week
before admission. There was no headache, chest
pain, hemoptysis, vomiting, diarrhea, or myalgia.
He visited a local hospital, where the white blood
cell count was 18.0 × 109/L. Serum creatinine was
3.9 mg/dL, urea nitrogen was 57.0 mg/dL, and
aspartate and alanine aminotransferase levels
were 18 and 25 U/L, respectively (Table). Chest
radiography showed pneumonic shadow over
the right upper lobe (Figure 1A). Ampicillin and
sulbactam were administered empirically. Sputum
culture yielded Pseudomonas aeruginosa and Candi-
da albicans.
His oxygen demand increased and a non-
rebreathing mask was applied on the 6th day of
hospitalization. Chest radiograph disclosed a
new opacity in the right upper lobe (Figure 1B).
Increased leukocytes, deterioration of renal func-
tion, and elevated liver aminotransferase level
were detected. The patient was transferred to our
medical intensive care unit for further evaluation
and management.
On admission, his temperature was 36.7°C,
pulse rate was 88 bpm, respiratory rate was 27
Table. Hemogram and blood chemistry data
7 days before admission On admission 7th hospital day 12th hospital day 23rd hospital day
White blood cell count (× 109/L) 18.00 30.13 16.90 7.36 14.98
Hemoglobin (g/dL) 8 8.3 9.7 10.5 9.3
Platelet (× 109/L) 355 132 132 146 100
Urea nitrogen (mg/dL) 57 126.4 194.6 116.3 87.2
Creatinine (mg/dL) 3.9 4.9 5.9 3.3 2.5
Total bilirubin (mg/dL) 1.42 0.73 0.44 0.56
Direct bilirubin (mg/dL) 1.19 0.51 0.13
Aspartate aminotransferase (U/L) 18 44 45 143 50
Alanine aminotransferase (U/L) 25 28 47 266 168
Alkaline phosphatase (U/L) 373 328
Gamma-glutamyltranspeptidase (U/L) 59 72
C-reactive protein (mg/dL) 25.64 8.62 0.46 0.16
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airbronchogram were also disclosed. However, re-
peated sputum Gram stain revealed no bacteria.
Because the rapid progression of pneumonia
resulted in acute respiratory distress syndrome but
no definite pathogens were identified, the serum
and sputum samples were sent to the Center for
Disease Control (CDC), Taiwan, in order to iden-
tify any unusual pathogens. The results showed that
the sputum culture yielded L. pneumophila sero-
group 6 and a low serologic titer (< 1:128) 7 days
after admission.
Levofloxacin was continued and the opacities
on chest radiograph subsided. Nevertheless,
multiple maculopapular rashes with oral mucosal
erosions appeared 1 week after admission. Drug-
related toxicodermia was suspected and levo-
floxacin was replaced by erythromycin. Steroid
and hydroxychloroquine were also prescribed.
The skin rashes did not progress further. Progres-
sive azotemia had been noted since admission.
Short-term hemodialysis for advanced azotemia
was performed on the 7th and 11th hospital days.
His pneumonia improved and he was extubated
successfully 10 days after admission.
Progressive elevation of liver transaminases
was detected from the 7th day of hospitalization.
Viral hepatitis markers were all negative. Erythro-
mycin was replaced by oral clarithromycin start-
ing on the 12th day for a total of 3 weeks. Steroids
were tapered and liver aminotransferases declined
gradually (Table). Fever and dyspnea subsequent-
ly resolved and the patient was discharged on the
28th day of hospitalization.
Discussion
Although Legionella spp. are consistently identified
as being among the most common causative agents
of severe community-acquired pneumonia, the per-
centage of subtypes and serogroups involved re-
mains uncertain.9 In this case of severe community-
acquired pneumonia due to L. pneumophila sero-
group 6 in an elderly man, chest radiographs re-
vealed progressive infiltrates that later developed
into hypoxemic respiratory failure. Legionella urine
antigen was negative and the titer of indirect fluo-
rescence antibody (IFA) was low. However, spu-
tum culture yielded L. pneumophila serogroup
6. The pneumonia resolved gradually after admin-
istration of levofloxacin, followed by erythromy-
cin and clarithromycin.
The patient was admitted because of high fever,
productive cough and dyspnea without head-
ache, chest pain, vomiting, diarrhea, myalgia or
skin rash. Chest radiography showed progression
of pneumonia patches. Abnormal liver function
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Figure 1.
Anteroposterior
radiograph of
the chest
obtained on
the: (A) 1st day
shows
consolidation
at the right
upper lobe;
(B) 7th day
shows
increased
opacity at the
right upper
lobe; (C) 10th
day shows
increased
diffuse air-
space opacities
in both lungs.
The patient was
intubated on
the same day.
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tests and acute renal failure developed despite beta-
lactam antibiotic therapy, but repeated sputum
smear revealed no bacteria. Therefore, pneumonia
caused by an atypical pathogen was considered.
Atypical pneumonia can be caused by Mycoplasma,
Chlamydia, Rickettsia, other bacteria, viruses, or
fungi. M. pneumoniae is the most commonly iden-
tified pathogen (20–30% of patients), followed by
Chlamydia pneumoniae (2–16%), L. pneumophila
(5%) and Coxiella burnetii (1–2%).10 Our patient
denied any recent travel history or contact with
animals. The symptoms and signs of our patient
were not specific to this disease. Diagnostic tests
including Mycoplasma pneumoniae antibody,
Chlamydia pneumoniae (TWAR) antigen, antigen of
adenovirus and respiratory syncytial virus, anti-
body of influenza virus and parainfluenza virus
were all negative. The CDC test results for Hanta
virus and Q fever were also negative. Urinary
Legionella antigen was negative, but sputum cul-
ture yielded L. pneumophila serogroup 6.
In several large surveys, Legionnaires’ disease
accounted for 3–8% of cases of community-
acquired pneumonia.11 Because of the specialized
laboratory tests necessary for diagnosis, legionel-
losis continues to be underdiagnosed. Moreover,
< 20% of all cases are proven by culture.12
In 1984, the US Centers for Disease Control
and Prevention (US CDC) published a retrospec-
tive survey of Legionella serogroups and species
in the United States. L. pneumophila was responsi-
ble for 80–85% of Legionella infections, and sero-
groups 1 and 6 were responsible for two-thirds
of all Legionella infections.3 Sputum culture, the
most sensitive test, however, was not widely
available. So, direct fluorescence antibody (DFA)
staining of respiratory tract secretions and tissue
was the diagnostic test performed.
Results of the international collaborative sur-
vey in North America, Europe, Australia, and New
Zealand, which identified culture-confirmed le-
gionellosis with sporadic community-acquired
legionellosis, showed that L. pneumophila consti-
tuted 91.5% of isolates. Serogroup 1 was predom-
inant (84.2%), followed by serogroup 6 (1.7%).13
The CDC in Taiwan reported that there were
50 patients with Legionnaire’s disease with de-
finite serogroups in Northern Taiwan between
January 2002 and June 2004. Forty-three (86%) of
these patients were infected by L. pneumophila se-
rogroup 1 and all were positive for urine Legionella
antigen. Furthermore, although 22 of the 43 pa-
tients had an elevated IFA titer, only 12 had a pos-
itive sputum culture. Legionnaire’s disease was
diagnosed by sputum culture in the remaining sev-
en of the 50 patients, three (6%) of whom were
infected by L. dumoffii, two (4%) by L. pneumophi-
la serogroup 6, and one each by L. pneumophila se-
rogroup 3 and 7, respectively.14
A few outbreaks of Legionnaires’ disease and
Pontiac fever have been caused by L. pneumophila
serogroup 6 associated with whirlpool baths and
spas in the United States.15,16 A study at a thermal
spa in Portugal revealed that the most common
isolates of Legionella spp. in spa water was L. pneu-
mophila serogroup 6. During the study, no clinical
cases of Legionnaires’ disease were observed, but
the antibody titers of the patients increased slight-
Figure 2.
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tomography
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and ground-
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with
airbronchogram.
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ly during their stay at the spa.17 Warm water seems
to facilitate the growth of many legionellae,18 and
very high numbers have been isolated from bio-
films associated with hot springs and from hot
water plumbing systems.19
Our patient denied any recent travel history or
visits to any whirlpool bath or spa. No other fam-
ily member became infected with Legionella
pneumonia. Since heated water could be a poten-
tial source of legionellosis and therapeutic spas
are widely distributed in Taiwan, a similar study
involving thermal spas in Taiwan is needed, with
attention to the risk of L. pneumophila serogroup
6-related Legionnaires’ disease.
Hospital-acquired outbreaks of Legionnaires’
disease have involved serogroups other than L.
pneumophila serogroup 1, especially serogroups 6
and 4, and other Legionella spp. such as L. micdadei,
L. dumoffii and L. bozemanii.4 Infecting strains of
L. pneumophila serogroup 6 may be transmitted
from hospital hot-water supply systems,5 portable
water systems,6 contaminated bronchoscopes,7 and
ice machines.8 Therefore, maintaining clean water
systems is an important strategy to minimize the
likelihood of transmission of Legionnaires’ disease
in health care facilities.
Our patient developed productive cough and
fever 2 weeks before admission, and chest radio-
graphy at admission revealed a pneumonia patch
over the right upper lobe. Hence, nosocomial pneu-
monia was considered to be unlikely in this patient.
The methods used to identify Legionella spp.
include culture, serologic tests, DFA staining, uri-
nary antigen assay, or polymerase chain reaction
(PCR), which are recommended in patients with
enigmatic pneumonia, in the presence of an epi-
demic, or if there is failure to respond to a beta-
lactam.20 Legionella urinary antigen test is a rela-
tively inexpensive, rapid, and clinically useful
test that detects antigen of L. pneumophila in
urine. The test has a sensitivity of 70% and a spe-
cificity that approaches 100%.10 The drawback
is that this test detects only L. pneumophila sero-
group 1, so although serogroup 1 accounts for the
large majority of cases of Legionnaires’ disease, a
few patients with presumed Legionella pneumonia
infected by other subtypes or serogroups of
Legionella spp. may be missed, resulting in inade-
quate antibiotic therapy.
DFA staining is a rapid diagnostic test. Its
sensitivity is less than that of culture because large
numbers of organisms need to be present before
they can be readily visualized.21
A number of serologic tests have been devel-
oped to detect antibodies to Legionella spp. Of
these tests, IFA has been the most extensively eval-
uated and is available commercially. The sensiti-
vity is in the range of 78–91%, and the specificity
is 99%.22 IFA has also been used by the CDC in
Taiwan for the diagnosis of Legionnaires’ disease
due to L. pneumophila serogroups 1–6. However,
the diagnosis of Legionella infection in our patient
was confirmed by sputum culture, not by eleva-
tion of serum antibody titer. IFA was used to de-
tect antibodies in patients with Legionnaires’
disease, but these antibody responses may be
serogroup-specific or may react with an antigen
common to L. pneumophila.23 Even in cases of
culture-confirmed Legionnaires’ disease, a four-
fold rise in antibody by IFA can be documented
in only 70–80% of patients, and seroconversion
following legionellosis may not occur for up to 2
months after the onset of illness.24
Past case definitions for Legionnaires’ disease
included a presumptive diagnosis based on an
elevated titer of > 1:256. Recent studies of patients
hospitalized with community-acquired pneumo-
nia showed that a single titer of > 1:256 did not
distinguish between Legionnaires’ disease and
pneumonia due to other agents.11 Moreover, the
need for testing of paired serum samples collected
3–6 weeks apart has diminished the use of sero-
logic studies. It is, thus, important to use reagents
that detect all major immunoglobulin (Ig) classes
(IgG, IgM, IgA) to increase test sensitivity.25
The definitive method for the diagnosis of le-
gionellosis is the culture of the organism. However,
Legionella does not grow on standard microbio-
logic medium. Sputum from patients suspected of
having Legionnaires’ disease should be cultured
regardless of quality.26 However, many hospital
laboratories in Taiwan either do not culture for
261J Formos Med Assoc | 2006 • Vol 105 • No 3
CAP due to Legionella pneumophila
Legionella or do so inadequately. Assays based on
PCR have been used to detect Legionella in urine
samples, bronchoalveolar-lavage fluid, and serum.
The primary advantage of this technique is the abil-
ity to detect Legionella rapidly and to detect species
other than L. pneumophila. Although PCR-based as-
says for the detection of Legionella in clinical sam-
ples are highly specific, they are not any more sen-
sitive than culture.21
We report this case to alert clinicians, since the
clinical and radiologic presentation of Legion-
naires’ disease is generally nonspecific, and numer-
ous studies have established Legionella spp. as a
common pathogen. We suggest that all patients
hospitalized for community-acquired pneumonia
should be routinely evaluated for Legionnaires’
disease. A Gram stain of sputum may also imme-
diately suggest the diagnosis. A finding of leuko-
cytes with a paucity of microorganisms should
raise the possibility of an atypical pneumonia and
the use of one rapid test for Legionella would be
ideal. Furthermore, we recommend the use of
diagnostic tests that include the combination of
urinary antigen assay and culture of respiratory
secretions on selective media. It should be empha-
sized that no laboratory test for Legionnaires’ dis-
ease detects all patients with the disease. There-
fore, treatment for Legionnaires’ disease is appro-
priate when there is clinical or epidemiologic evi-
dence of the disease, despite negative diagnostic
test results. Treatment should be initiated as rap-
idly as is feasible or continued even if the results
of Legionella-specific tests are negative.20
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